4//SEC Filing
Gold Lawrence Marshall 4
Accession 0001213900-21-040776
CIK 0001690080other
Filed
Aug 5, 8:00 PM ET
Accepted
Aug 6, 4:20 PM ET
Size
8.0 KB
Accession
0001213900-21-040776
Insider Transaction Report
Form 4
Gold Lawrence Marshall
Director
Transactions
- Award
Common Stock
2021-08-04$7.56/sh+4,629$34,995→ 6,730 total - Award
Non-Qualified Stock Option (right to buy)
2021-08-04+60,000→ 60,000 totalExercise: $7.56Exp: 2031-08-04→ Common Stock (60,000 underlying)
Footnotes (3)
- [F1]Issued in consideration for serving on the Board of Directors, as a Member of the Audit and Compensation Committee of the Board of Directors, and as Chairman of the Nominating and Corporate Governance Committee of the Board of Directors, for the quarters ended March 31, 2021 and June 30, 2021. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) pursuant to Rule 16b-3.
- [F2]Granted in consideration for services rendered and to be rendered as a member of the Board of Directors. Granted under the registrant's 2020 Omnibus Incentive Plan. Exempt from Section 16(b) of the Securities Exchange Act of 1934 pursuant to Rule 16b-3 promulgated under the Exchange Act.
- [F3]The Options vest at the rate of 1/48th of such options ratably on a monthly basis over the following 48 months following the grant date, on the last day of each calendar month (beginning on August 31, 2021), subject to the holder's continued service to the Company.
Documents
Issuer
180 Life Sciences Corp.
CIK 0001690080
Entity typeother
Related Parties
1- filerCIK 0001355868
Filing Metadata
- Form type
- 4
- Filed
- Aug 5, 8:00 PM ET
- Accepted
- Aug 6, 4:20 PM ET
- Size
- 8.0 KB